GSK Investigational Site — Chapel Hill, North Carolina

GSK Investigational Site is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 93 clinical trials with 7 currently active.

Therapeutic areas: Lupus Nephritis, Infection, Human Immunodeficiency Virus, Epilepsy.

Sponsors: Human Genome Sciences Inc., a GSK Company, ViiV Healthcare, GlaxoSmithKline.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chapel Hill

Browse all research sites in North Carolina · View every site in Chapel Hill

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 93 clinical trials on record, with 7 currently active. Their work covers Lupus Nephritis, Infection, Human Immunodeficiency Virus, Epilepsy.

Is GSK Investigational Site accredited by Crixeo Clinical Trials?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.